The University of Texas MD Anderson Cancer Center has signed a new collaboration agreement with Amorfix Life Sciences in which antibodies thought to help direct cancer treatments will be used by the center to identify misfolded proteins, which are incorrectly created protein cells that are part of the development of lung cancer.
http://bionews-tx.com/news/2013/04/26/lung-cancer-research-at-the-md-anderson-cancer-center-focuses-on-misfolded-proteins/
No comments:
Post a Comment